ASPI (STOCKS)
ASP Isotopes Inc. Common Stock
$5.080100
+0.600100 (+13.40%)
Prev close: $4.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Paul E. Mann
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $631.81M
- Employees
- 136
- P/E (TTM)
- -3.14
- P/B (TTM)
- 2.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.14 | $-0.10 | -0.0380 | -37.25% |
|
Jun 2025 (Q2)
|
$-1.03 | $-0.11 | -0.9178 | -818.00% |
|
Mar 2025 (Q1)
|
$-0.12 | $-0.10 | -0.0180 | -17.65% |
|
Dec 2024 (Q4)
|
$-0.13 | $-0.09 | -0.0382 | -41.61% |
Financial Statements
| Revenues | $23.85M |
| Benefits Costs and Expenses | $183.41M |
| Cost Of Revenue | $20.44M |
| Costs And Expenses | $183.41M |
| Gross Profit | $3.41M |
| Nonoperating Income/Loss | -$99.65M |
| Operating Expenses | $63.31M |
| Research and Development | $12.36M |
| Other Operating Expenses | $50.96M |
| Operating Income/Loss | -$59.91M |
| Income/Loss From Continuing Operations After Tax | -$159.84M |
| Income/Loss From Continuing Operations Before Tax | -$159.56M |
| Income Tax Expense/Benefit | $282.00K |
| Income Tax Expense/Benefit, Current | $237.00K |
| Income Tax Expense/Benefit, Deferred | -$45.00K |
| Net Income/Loss | -$159.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $15.25M |
| Net Income/Loss Attributable To Parent | -$159.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$159.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.11 |
| Diluted Earnings Per Share | -$2.11 |
| Basic Average Shares | 83,013,594 |
| Diluted Average Shares | 83,013,594 |
| Assets | $498.02M |
| Current Assets | $399.92M |
| Inventory | $1.10M |
| Prepaid Expenses | $13.84M |
| Other Current Assets | $384.98M |
| Noncurrent Assets | $98.10M |
| Fixed Assets | $33.45M |
| Other Non-current Assets | $64.65M |
| Liabilities | $235.12M |
| Current Liabilities | $32.70M |
| Accounts Payable | $5.76M |
| Other Current Liabilities | $26.94M |
| Noncurrent Liabilities | $202.43M |
| Long-term Debt | $14.36M |
| Other Non-current Liabilities | $188.07M |
| Equity | $262.90M |
| Equity Attributable To Noncontrolling Interest | $58.75M |
| Equity Attributable To Parent | $204.15M |
| Liabilities And Equity | $498.02M |
| Net Cash Flow From Operating Activities | -$37.78M |
| Net Cash Flow From Operating Activities, Continuing | -$37.78M |
| Net Cash Flow From Investing Activities | -$110.79M |
| Net Cash Flow From Investing Activities, Continuing | -$110.79M |
| Net Cash Flow From Financing Activities | $371.60M |
| Net Cash Flow From Financing Activities, Continuing | $371.60M |
| Exchange Gains/Losses | $647.00K |
| Net Cash Flow | $223.67M |
| Net Cash Flow, Continuing | $223.03M |
| Comprehensive Income/Loss | -$155.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $15.66M |
| Comprehensive Income/Loss Attributable To Parent | -$170.80M |
| Other Comprehensive Income/Loss | $4.71M |